PTH antibody (N-Term)
Quick Overview for PTH antibody (N-Term) (ABIN4949381)
Target
See all PTH AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- N-Term
-
Purpose
- PTH Antibody / N-Terminal (azide and preservative free)
-
Purification
- Protein A affinity chromatography
-
Immunogen
- A synthetic peptide from the N-terminal region of human Parathyroid hormone was used as the immunogen for the PTH antibody.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal dilution of the PTH antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the PTH antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- PTH (Parathyroid Hormone (PTH))
-
Alternative Name
- PTH
-
Target Type
- Hormone
-
Background
- PTH/Parathyroid hormone is a hormone produced by the parathyroid gland that regulates the concentration of calcium and phosphorus in extracellular fluid. This hormone elevates blood Ca2+ levels by dissolving the salts in bone and preventing their renal excretion. It is produced in the parathyroid gland as an 84 amino acid single chain polypeptide. It can also be secreted as N-terminal truncated fragments or C-terminal fragments after intracellular degradation, as in case of hypercalcemia. Defects in this gene are a cause of familial isolated hypoparathyroidism (FIH), also called autosomal dominant hypoparathyroidism or autosomal dominant hypocalcemia. FIH is characterized by hypocalcemia and hyperphosphatemia due to inadequate secretion of parathyroid hormone. Symptoms are seizures, tetany and cramps. FIH exist both as autosomal dominant and recessive forms of hypoparathyroidism.
-
UniProt
- P01270
-
Pathways
- cAMP Metabolic Process, Regulation of Carbohydrate Metabolic Process
Target
-